Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Emmenegger

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
EMBO Molecular Medicine|August 11, 2020
Protective anti-prion antibodies in human immunoglobulin repertoiresAssunta Senatore, Karl Frontzek, Marc Emmenegger, et al.
Plos Pathogens|October 27, 2021
Novel regulators of PrPC biosynthesis revealed by genome-wide RNA interferenceDaniel Heinzer, Merve Avar, Daniel Patrick Pease, et al.
Plos Pathogens|February 2, 2022
Correction: Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteinsMarc Emmenegger, Sreedhar Saseendran Kumar, Vishalini Emmenegger, et al.
Plos Pathogens|December 3, 2021
Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteinsMarc Emmenegger, Sreedhar Saseendran Kumar, Vishalini Emmenegger, et al.
Clinical Immunology (Orlando, Fla.)|November 23, 2023
Antiphospholipid antibodies are enriched post-acute COVID-19 but do not modulate the thrombotic riskMarc Emmenegger, Vishalini Emmenegger, Srikanth Mairpady Shambat, et al.
Scientific Reports|November 17, 2022
Serological fingerprints link antiviral activity of therapeutic antibodies to affinity and concentrationSebastian Fiedler, Sean R A Devenish, Alexey S Morgunov, et al.
Nature Communications|May 12, 2026
Gpnmb defines a phagocytic state of microglia linked to cell death in prion disease mouse modelDavide Caredio, Giovanni Mariutti, Lisa Polzer, et al.
ACS Infectious Diseases|March 30, 2022
Microfluidic Antibody Affinity Profiling Reveals the Role of Memory Reactivation and Cross-Reactivity in the Defense Against SARS-CoV-2Viola Denninger, Catherine K Xu, Georg Meisl, et al.
The EMBO Journal|October 18, 2022
An arrayed genome-wide perturbation screen identifies the ribonucleoprotein Hnrnpk as rate-limiting for prion propagationMerve Avar, Daniel Heinzer, Alana M Thackray, et al.
Iscience|July 25, 2022
Both COVID-19 infection and vaccination induce high-affinity cross-clade responses to SARS-CoV-2 variantsMarc Emmenegger, Sebastian Fiedler, Silvio D Brugger, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
EMBO Molecular Medicine|August 11, 2020
Protective anti-prion antibodies in human immunoglobulin repertoiresAssunta Senatore, Karl Frontzek, Marc Emmenegger, et al.
Plos Pathogens|October 27, 2021
Novel regulators of PrPC biosynthesis revealed by genome-wide RNA interferenceDaniel Heinzer, Merve Avar, Daniel Patrick Pease, et al.
Plos Pathogens|February 2, 2022
Correction: Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteinsMarc Emmenegger, Sreedhar Saseendran Kumar, Vishalini Emmenegger, et al.
Plos Pathogens|December 3, 2021
Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteinsMarc Emmenegger, Sreedhar Saseendran Kumar, Vishalini Emmenegger, et al.
Clinical Immunology (Orlando, Fla.)|November 23, 2023
Antiphospholipid antibodies are enriched post-acute COVID-19 but do not modulate the thrombotic riskMarc Emmenegger, Vishalini Emmenegger, Srikanth Mairpady Shambat, et al.
Scientific Reports|November 17, 2022
Serological fingerprints link antiviral activity of therapeutic antibodies to affinity and concentrationSebastian Fiedler, Sean R A Devenish, Alexey S Morgunov, et al.
Nature Communications|May 12, 2026
Gpnmb defines a phagocytic state of microglia linked to cell death in prion disease mouse modelDavide Caredio, Giovanni Mariutti, Lisa Polzer, et al.
ACS Infectious Diseases|March 30, 2022
Microfluidic Antibody Affinity Profiling Reveals the Role of Memory Reactivation and Cross-Reactivity in the Defense Against SARS-CoV-2Viola Denninger, Catherine K Xu, Georg Meisl, et al.
The EMBO Journal|October 18, 2022
An arrayed genome-wide perturbation screen identifies the ribonucleoprotein Hnrnpk as rate-limiting for prion propagationMerve Avar, Daniel Heinzer, Alana M Thackray, et al.
Iscience|July 25, 2022
Both COVID-19 infection and vaccination induce high-affinity cross-clade responses to SARS-CoV-2 variantsMarc Emmenegger, Sebastian Fiedler, Silvio D Brugger, et al.
Pageof 3